Currently, as a VP, Associate Creative Director with the BGB Group, he is leading a highly skilled team developing HCP materials and campaign work for LEQEMBI, the first approved treatment that reduces the rate of Alzheimer's disease progression. Along with the creation of impactful creative he demonstrates his strategic skills by collaborating with clients and cross functional teams successfully growing his business.
Prior to BGB Group, as an Associate Creative Director at Wildtype Health, he applied his skills in creative direction and marketing communications, crafting compelling data-driven healthcare professional campaigns for one of the largest immunology brand, KEYTRUDA.
Before joining Wildtype Health, Robert worked as a Creative Director at Syneos Health Communications New York, where he developed unique and effective PR strategies and solutions for clients such as Pfizer, Amgen, Janssen, Medtronic, and Sage Therapeutics. He also led his own design firm, where he collaborated with clients such as the National Multiple Sclerosis Society and Columbia University Medical Center, creating award-winning works that also produced results. Robert is driven by his vision, strategic focus, and passion for communications in the healthcare and pharmaceutical fields, and he strives to deliver impactful and innovative promotional tactics across print, digital, video, and multimedia platforms.
“Robert’s work is superlative at every turn. I’ve never been disappointed in any aspect of the work. He’s a high energy talented executive who has the creative chops to do great work. A very unusual combination indeed!”